Colmédica

61
Colmédica is an Android app from Proximate Mobile Apps in the Medical category, currently rated 4.0★ across 15,188 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 61: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Medical complexity ×1.55 | +$27K |
| 🌐 Cross-platform reach (iOS + Android) | +$43K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 🏷 Medical category multiple | +12% |
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Below median · 46/100MID TIERunderperforming peers- 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.0★ across 15,188 reviews — strong (top 10%).
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Mid install base (15,188 ratings)METRIC | +$5,500 | |
| bugsREVIEW | −$1,800 | |
| Mature app (13y old)METRIC | +$1,500 | |
| Good rating (4.0★)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Colmédica
- Developer
- Proximate Mobile Apps
- Bundle ID
- com.proximate.colmedica
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.proximateapps.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $11/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📈Ratings growth15,188 ratings+8% lifetimeShow 3-year history estimate ▾
📝 About this app
Thanks to our Colmédica App for smartphones and tablets, you can access the information about our services that you most frequently and urgently need, directly and immediately.
Video call features for Medical Authorizations and Medical Guidance Service (SOM) via video call.
Whenever you need us, a healthcare professional will be available through the SOM video call feature and will provide you with information about:
• Managing your health situation at home or in the office.
• The nearest hospital based on your location.… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
More by Proximate Mobile Apps
View all →Why high confidence: 15,188 ratings · no founder-verified revenue (model estimate only).




